winclove logo rechtsboven COPY COPY COPY

 

LATEST STUDIES

Read the scientific article 

Read the scientific article 

balk

Modulating the Gut microbiota in IBD patients

The imbalance of gut homeostasis is associated with the onset of many severe pathological conditions, such as inflammatory bowel disease (IBD), a chronic gastrointestinal disorder increasing in incidence and severely influencing affected individuals. Despite the recent development of next generation sequencing and bioinformatics. The current scientific knowledge of specific triggers and diagnostic markers to improve interventional approaches in IBDS is still scarce.

In a recently published review the currently available and emerging therapeutic options in modulating composition and metabolic activity of gut microbiota in patients affected by IBD are discussed. These include among others probiotics, prebiotics, synbiotics and fecal microbiota transplantation.

These insights can be used in the future to stratify individuals more precisely, consequently apply more efficient nutritional and treatment interventions and thus make a major step forwards a true personalized medicine.

 

 

Impact of the gut microbiota on inflammation, obesity and metabolic disease

New Studoes_42

A selection of latest published reviews on the

microbiome and probiotics.

New Studoes_41

The human gut harbors more than 100 trillion microbial cells, which have an essential role in human metabolic regulation via  their symbiotic interactions with the host. Alterations in the gut microbiota have been associated with increased metabolic and immune disorders.

However, the exact mechanisms that link specific variations in the composition of the gut microbiota with the development of obesity and metabolic diseases remain unknown, due to the complex etiology of these  diseases.

In a recently published review, the current knowledge about the mechanistic interactions between the gut microbiota, host energy metabolism and the host immune system in the context of obesity and metabolic disease is discussed. This knowledge can be used to improve the stratification of populations at risk for developing metabolic diseases and offer novel perspectives for personalized healthcare, within which clinicians might be able to tailor therapy on the basis of individual habits and predispositions.

Newly published reviews

9/11
Klik op het menu voor inhoud en andere functies.

Gebruik de pijlen aan de zijkant om door het magazine te bladeren.
Loading ...